Office intrauterine morcellation for retained products of conception.
Minim Invasive Ther Allied Technol
; 32(6): 323-328, 2023 Dec.
Article
en En
| MEDLINE
| ID: mdl-37493491
ABSTRACT
OBJECTIVE:
Proposing hysteroscopic morcellation (HM) as a surgical-therapeutic approach in the treatment of retained products of conception (RPOC) to prevent intrauterine adhesions (IUAs).DESIGN:
Prospective analysis.SETTING:
A teaching and university hospital. PATIENTS Women with RPOC.INTERVENTIONS:
Office -HM with 'Truclear 5 C'. MATERIAL ANDMETHODS:
Twenty-two consecutive patients presenting with trophoblastic residue retention after miscarriage and interruption of pregnancy or placenta remnants after cesarean section or delivery were enrolled. These women underwent office-HM with 'Truclear 5 C'. Primary outcomes were median time and rate of hospitalization. The quality of the specimen was also analyzed. A hysteroscopic second look for IUAs was performed.RESULTS:
Mean procedure time was six minutes (SD ± 5). Tissue samples had a mean collection size 2.5 cm3+0.9. 38% of the samples had spotting or abnormal vaginal discharge. Dilatation of the cervical canal was not performed in any case. Second-look hysteroscopy did not show any de novo IUAs in any of the enrolled patients.CONCLUSIONS:
In the hysteroscopic treatment of RPOC, HM is a valid choice in an office setting without the use of cervical dilatation. Removal of RPOC was uneventful in all cases, simple and carried out faster without any adverse outcomes.Palabras clave
Texto completo:
1
Colección:
01-internacional
Asunto principal:
Complicaciones del Embarazo
/
Enfermedades Uterinas
/
Morcelación
Límite:
Female
/
Humans
/
Pregnancy
Idioma:
En
Revista:
Minim Invasive Ther Allied Technol
Asunto de la revista:
TERAPEUTICA
Año:
2023
Tipo del documento:
Article
País de afiliación:
Italia